Please see below to view the lung trials taking place within the Peninsula Cancer Network
BTOG2 A British Thoracic Oncology Group (BTOG) phase III trial of gemcitabine plus cisplatin at 80 mg/m2 vs gemcitabine plus cisplatin at 50mg/m2 gemcitabine plus carboplatin AUC 5 in stage IIIB/IV non small cell lung cancer (NSCLC)
CONVERT:A 2-arm randomised controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status
ET Trial -A multicentre, randomised, phase III trial of platinum-based chemotherapy versus non-platinum chemotherapy, after ERCC1 stratification, in patients with advanced/metastatic non-small cell lung cancer
FRAGMATIC A radomised phase III clinical trial investigating the effect of FRAGMin added to standard Therapy in patients with lung cancer
Lung-SEARCH-A randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group.
LungStar A mulitcentre phase III radomised double blind placebo controlled trial of pravastain added to first-line standard chemotherapy in patients with small cell lung cancer
Julian Peto's Mesothelioma and Lung Cancer Study (MALCS) A POPULATION BASED CASE-CONTROL STUDY OF MESOTHELIOMA AND LUNG CANCER IN RELATION TO OCCUPATION AMONG BRITISH MEN AND WOMEN UNDER THE AGE OF 60
TACTIC:Phase II Randomised study of whole brain radiotherapy and erlotinib in patients with advanced NSCLC with brain metastases